Evidence map›Paper›PMID 40674423›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Deletion of p63 exon 13 in mice reveals C-terminal isoform-specific functions in epithelial development.

Anna Maria Lena, Artem Smirnov, Mara Mancini, Manuela Montanaro, Fabiola Ciccosanti, Valeria Foti, Roberta Nardacci, Gian Maria Fimia, Mara Mavilio, Massimo Federici and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anna Maria Lena *Department of Experimental Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.ORCID 0000-0001-6285-9927
Artem Smirnov *Department of Experimental Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.ORCID 0000-0002-1575-8725
Mara ManciniDepartment of Experimental Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.ORCID 0000-0001-5173-4854
Manuela MontanaroDepartment of Experimental Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.ORCID 0000-0001-8441-3731
Fabiola CiccosantiNational Institute for Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico "Lazzaro Spallanzani", Rome 00149, Italy.ORCID 0000-0003-0481-6878
Valeria FotiDepartment of Experimental Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.
Roberta NardacciNational Institute for Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico "Lazzaro Spallanzani", Rome 00149, Italy.ORCID 0000-0002-9209-1207
Gian Maria FimiaNational Institute for Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico "Lazzaro Spallanzani", Rome 00149, Italy.
Mara MavilioDepartment of Systems Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.
Massimo FedericiDepartment of Systems Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.
Alessandro MaurielloDepartment of Experimental Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.ORCID 0000-0002-7351-5676
Mauro PiacentiniNational Institute for Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico "Lazzaro Spallanzani", Rome 00149, Italy.
Gerry MelinoDepartment of Experimental Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.ORCID 0000-0001-9428-5972
Eleonora CandiDepartment of Experimental Medicine, University of Rome "Tor Vergata", Rome 00133, Italy.ORCID 0000-0001-8332-4825

Funding

Fondazione AIRC per la ricerca sul cancro ETS (AIRC) ID31044Ministero della Salute (Italy Ministry of Health) PNRR-MAD-2022-12375755
6 · The paper itself

Abstract

The transcription factor p63 is an essential regulator of epithelial development. Yet, the complexity at the 3'UTR, which gives rise to the three distinct C-terminal protein isoforms (α, β, and γ), remains unresolved and opens an investigation on the in vivo role of the C-terminus. This region, codified by exon 13, harbors genetic mutations leading to AEC syndrome. Here, we generated a mouse with a deletion of p63 exon 13 in keratin-14-expressing tissues and employed transcriptome, genome-wide occupancy, and interactome studies to characterize the role of the p63 C-terminus in vivo. In this model mouse, the p63 protein is expressed at the correct level in time and space but predominantly as the β isoform instead of the α isoform, thereby providing insights into the function of the C-terminus. We show that p63β interacts more readily with the core promoter transcription machinery and p63α-depleted isoforms bind more frequently the promoter region of target genes, resulting in inappropriate overexpression of extracellular matrix organization genes in the skin. This leads to the aberrant adhesion of epidermal keratinocytes to the basal lamina and triggers systemic inflammation, growth abnormalities, and premature death. We found a significant role of the full-length ΔNp63a isoform which cannot be substituted by the other isoforms (β or γ). Our studies highlight a crucial role for p63α in correctly orchestrating the gene expression program to ensure proper formation of epithelia.

Indexed as

ExonsPhosphoproteinsTrans-ActivatorsAnimalsEpitheliumKeratinocytesMiceProtein IsoformsPhosphoproteinsProtein IsoformsTrans-ActivatorsTrp63 protein, mouseadhesionenhancersp63SAM domainsΔNp63

Identifiers

PMID40674423
PMCPMC12304987

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.